Introduction: Using a rat model, we aimed to confirm the inhibitory effect of dorsal spinal root (afferent) stimulation and test if bilateral stimulation is more effective than unilateral stimulation. External urethral sphincter (EUS) electromyography (EMG) is also assessed in conjunction with cystometrogram. Materials and Methods: Eighteen female Sprague-Dawley rats were tested following urethane anesthesia. Via urethral catheterization, the bladder was infused with normal saline to evoke rhythmic bladder reflex contractions (BRC). L6 spinal nerves were isolated and stimulated. Results: L6 stimulation was effective in inhibiting BRC. L6 bilateral dorsal root (DR) stimulation of 50% intensity was required to cause inhibition as compared to unilateral stimulation. In EUS EMG recordings, there was a strong association between EUS EMG activities and bladder contraction. When the bladder contraction was inhibited effectively by L6 DR stimulation, a considerable reduction was also found in the EUS EMG activities. Conclusions: L6 DR stimulation abolished BRC in our rat model. Bilateral L6 DR stimulation produced a 50% reduction in stimulation intensity, providing a similar BRC block. Abolishing BRC also appeared to coincide with a reduction in EUS EMG, implicating that sacral neuromodulation might act centrally, at least rostrally at the T8-9 spinal level.

1.
Milsom I, Abrams P, Cardozo L, et al: How widespread are the symptoms of an overactive bladder and how are they managed? A population-based prevalence study. BJU Int 2001;87:760-766.
2.
Stewart WF, Van Rooyen JB, Cundiff GW, et al: Prevalence and burden of overactive bladder in the United States. World J Urol 2003;20:327-336.
3.
Irwin DE, Milsom I, Hunskaar S, et al: Population-based survey of urinary incontinence, overactive bladder, and other lower urinary tract symptoms in five countries: results of the EPIC study. Eur Urol 2006;50:1306-1314; discussion 1314-1315.
4.
Milsom I, Kaplan SA, Coyne KS, et al: Effect of bothersome overactive bladder symptoms on health-related quality of life, anxiety, depression, and treatment seeking in the United States: results from EpiLUTS. Urology 2012;80:90-96.
5.
Schmidt RA, Jonas U, Oleson KA, et al: Sacral nerve stimulation for treatment of refractory urinary urge incontinence. Sacral Nerve Stimulation Study Group. J Urol 1999;162:352-357.
6.
Janknegt RA, Weil EH, Eerdmans PH: Improving neuromodulation technique for refractory voiding dysfunctions: two-stage implant. Urology 1997;49:358-362.
7.
van Kerrebroeck PE, van Voskuilen AC, Heesakkers JP, et al: Results of sacral neuromodulation therapy for urinary voiding dysfunction: outcomes of a prospective, worldwide clinical study. J Urol 2007;178:2029-2034.
8.
Chughtai B, Sedrakyan A, Isaacs A, et al: Long term safety of sacral nerve modulation in medicare beneficiaries. Neurourol Urodyn 2015;34:659-663.
9.
Wang Y, Hassouna MM: Neuromodulation reduces c-fos gene expression in spinalized rats: a double-blind randomized study. J Urol 2000;163:1966-1970.
10.
Fowler CJ, Swinn MJ, Goodwin RJ, et al: Studies of the latency of pelvic floor contraction during peripheral nerve evaluation show that the muscle response is reflexly mediated. J Urol 2000;163:881-883.
11.
Kavia R, DasGupta R, Critchley H, et al: A functional magnetic resonance imaging study of the effect of sacral neuromodulation on brain responses in women with Fowler's syndrome. BJU Int 2010;105:366-372.
12.
Marcelissen TA, Leong RK, Serroyen J, et al: The use of bilateral sacral nerve stimulation in patients with loss of unilateral treatment efficacy. J Urol 2011;185:976-980.
13.
Sievert KD, Amend B, Gakis G, et al: Early sacral neuromodulation prevents urinary incontinence after complete spinal cord injury. Ann Neurol 2010;67:74-84.
14.
Ren J, Chew DJ, Biers S, et al: Electrical nerve stimulation to promote micturition in spinal cord injury patients: a review of current attempts. Neurourol Urodyn 2015, Epub ahead of print.
15.
Vignes JR, Deloire M, Petry K: Animal models of sacral neuromodulation for detrusor overactivity. Neurourol Urodyn 2009;28:8-12.
16.
Yoshiyama M, Roppolo JR, Takeda M, et al: Effects of urethane on reflex activity of lower urinary tract in decerebrate unanesthetized rats. Am J Physiol Renal Physiol 2013;304:F390-F396.
17.
Schurch B, Reilly I, Reitz A, et al: Electrophysiological recordings during the peripheral nerve evaluation (PNE) test in complete spinal cord injury patients. World J Urol 2003;20:319-322.
18.
Su X, Nickles A, Nelson DE: Quantification of effectiveness of bilateral and unilateral neuromodulation in the rat bladder rhythmic contraction model. BMC Urol 2013;13:34.
19.
Kaufmann S, Naumann CM, Hamann MF, et al: Unilateral vs bilateral sacral neuromodulation in pigs with formalin-induced detrusor hyperactivity. BJU Int 2009;103:260-263.
20.
Seif C, Eckermann J, Bross S, et al: Findings with bilateral sacral neurostimulation: sixty-two PNE-tests in patients with neurogenic and idiopathic bladder dysfunctions. Neuromodulation 2004;7:141-145.
21.
Chew DJ, Zhu L, Delivopoulos E, et al: A microchannel neuroprosthesis for bladder control after spinal cord injury in rat. Sci Transl Med 2013;5:210ra155.
22.
D'Amico SC, Collins WF 3rd: External urethral sphincter motor unit recruitment patterns during micturition in the spinally intact and transected adult rat. J Neurophysiol 2012;108:2554-2567.
23.
Chang HY, Cheng CL, Chen JJ, et al: Serotonergic drugs and spinal cord transections indicate that different spinal circuits are involved in external urethral sphincter activity in rats. Am J Physiol Renal Physiol 2007;292:F1044-F1053.
24.
Kakizaki H, Fraser MO, De Groat WC: Reflex pathways controlling urethral striated and smooth muscle function in the male rat. Am J Physiol 1997;272(5 pt 2):R1647-R1656.
25.
Zhang F, Zhao S, Shen B, et al: Neural pathways involved in sacral neuromodulation of reflex bladder activity in cats. Am J Physiol Renal Physiol 2013;304:F710-F717.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.